Abstract P6-10-07: CDK2 Inhibition with BLU-222 in Combination with Ribociclib Demonstrates Robust Antitumor Activity in Pre-Clinical Models of CDK4/6 Inhibitor-Naïve and -Resistant HR+/HER2- Breast Cancer
Cancer Research（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined